2310036D22Rik antikoerper, 5830455K21Rik antikoerper, 6430519M21Rik antikoerper, AI428776 antikoerper, AI661344 antikoerper, LRRGT00101 antikoerper, MGC81788 antikoerper, tmem106b antikoerper, zgc:114147 antikoerper, zgc:64013 antikoerper, transmembrane protein 106B antikoerper, transmembrane protein 106B S homeolog antikoerper, transmembrane protein 106Bb antikoerper, transmembrane protein 106b antikoerper, transmembrane protein 106Ba antikoerper, TMEM106B antikoerper, Tmem106b antikoerper, tmem106b.S antikoerper, tmem106b antikoerper, tmem106bb antikoerper, Tsp_02056 antikoerper, Tsp_01553 antikoerper, t106b antikoerper, tmem106ba antikoerper
Hintergrund
Transmembrane protein 106B (TMEM106B) is a single-pass transmembrane protein that is thought to be a novel risk factor for frontotemporal lobar degeneration (FTLD), a group of clinically, pathologically and genetically heterogeneous disorders associated with atrophy in the frontal lobe and temporal lobe of the brain. The actual role of TMEM106B, and that of the closely related protein TMEM106A are still undetermined.Synonyms: Transmembrane protein 106B